Navigation Links
New Combination Locking Cap Designed to Protect Children and Teens From Prescription Medications
Date:9/26/2011

LINCOLN, Calif., Sept. 26, 2011 /PRNewswire/ -- Safely storing prescription medications has always been a challenge for parents and other prescription holders. Now, an innovative new device allows prescription holders to safely secure and store dangerous medications—in a small, convenient and more portable container.

(Photo: http://photos.prnewswire.com/prnh/20110926/SF75139)

Developed by CAP-N-LOCK, LLC., The Locking Cap is a combination locking cap designed to work with existing prescription medication bottles. The Locking Cap was designed to help families prevent unauthorized and undetected use of prescription medications for non-medical purposes. With a four-digit combination locking mechanism and sturdy PVC construction, it is easy to use, but virtually impossible to get past without detection.

"The Locking Cap eliminates unauthorized access to dangerous prescription drugs," said Joseph Simpson, President and product designer for CAP-N-LOCK. "The Locking Cap is very easy to operate. It protects families by blocking access to curious children and experimental teens. Plus, it features a compact design that allows for easy access and storage when traveling and at home."

The Locking Cap is designed and manufactured in the United States and is currently available in national pharmacies and online at http://www.TheLockingCap.com

About CAP-N-LOCK, LLC.

CAP-N-LOCK specializes in family safety product design, development, manufacturing and marketing. The non-medical use and abuse of prescription drugs is a serious and growing public health problem in the U.S. and is rapidly becoming a global epidemic. The majority of people use prescription medications responsibly; however, an estimated 48 million people in the U.S. (ages 12 and older) have used prescription drugs for non-medical reasons. The Locking Cap was created to protect families and help prevent prescription drug abuse and overdoses. For more information about The Locking Cap, visit http://www.TheLockingCap.com or call (408) 206-0120.  

Available at Ralphs, SaveMart, and Lucky Pharmacies.

Contact:
Deborah Simpson, Chairman & CEO, CAP-N-LOCK, LLC., at (408) 206-0120 or dsimpson@TheLockingCap.com


'/>"/>
SOURCE CAP-N-LOCK, LLC.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pearl Therapeutics Bronchodilator Combination PT003 Provides Superior Inspiratory Capacity Compared to Spiriva®
2. SANYO Adds New MPR Series Biomedical Refrigerator/Freezer Combination Unit
3. Specialty Silicone Fabricators Adds Analytical Laboratory to Bolster Combination Product Services
4. Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
5. Takeda Resubmits New Drug Applications in the U.S. for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
6. Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed-Dose Combination of PREZISTA® and Cobicistat
7. Launch of Nuromol a New Painkiller Combination
8. ReportsnReports - Multitargeted Therapies: Promiscuous Drugs and Combination Therapies
9. Pearl Therapeutics Advances Its Long-Acting Bronchodilator Combination Product Candidate into Four Additional Phase 2 Studies
10. Argos Therapeutics Arcelis™ Immunotherapy for the Treatment of Renal Cell Carcinoma (RCC) in Combination With Sunitinib Demonstrates Strong Immunologic Response That Correlates to Improved Clinical Outcomes
11. All-Oral Combination Study with PSI-7977 for HCV Genotypes 1, 2 and 3 Initiated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... , July 13, 2017  New York City-based market research ... markets should be aware of.  From new products to new ... detailed in a recently completed study, Potential Pipeline Disruptors ... 1.  Age-Driven Growth - True ... been aware of the impact the growing population and, to ...
(Date:7/11/2017)...  Bayer has awarded grants totaling more than $2 million ... prestigious Bayer Hemophilia Awards Program (BHAP). Four U.S. clinicians and ... and Uniformed Services University of the Health Sciences in ... recipients were announced last night during a reception at the ... Berlin, Germany . ...
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... has agreed to schedule an End-of-Phase II meeting with ... its oral insulin capsule ORMD-0801 in the treatment of ... and secondary endpoints by indicating a statistically significant lowering ...
Breaking Medicine Technology:
(Date:7/27/2017)... Plano, TX (PRWEB) , ... July 27, 2017 ... ... technology and outsourced services, announces the internal promotion of Elrene Clinkscales to Vice ... Operations – Claims & Remittance Management, reporting to Derek Morkel, chief executive officer ...
(Date:7/27/2017)... ... 2017 , ... Team Novo Nordisk, the world’s first all-diabetes professional cycling team, ... a stagiaire for the remainder of the 2017 season. One of our best development ... Tour of Utah. , “Every season we are excited to move an athlete from ...
(Date:7/26/2017)... ... July 26, 2017 , ... Written By: Ashley D. Beall, ... in drug therapy for patients living with relapsing and primary multiple sclerosis that ... cell targeted therapy that has been proven to significantly reduce signs of disease ...
(Date:7/26/2017)... ... July 26, 2017 , ... “We are dentists and we thought there ... Jose, Calif., “so we invented the MAGNETIC/ LOCK BRACKETS.” , The patent-pending MAGNETIC/ LOCK ... In doing so, it offers an effective alternative to traditional braces. As a result, ...
(Date:7/26/2017)... ... July 26, 2017 , ... “We are thrilled to be ... for patients to schedule an appointment online in real time,” said Keith English, LocalMed ... Smiles provider directory will bring more Six Month Smiles patients to their providers.” , ...
Breaking Medicine News(10 mins):